Dr. Mohamed R. Elnagar graduated as a PhD (Joint-supervision) specialized in Pharmacology and Toxicology from Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. He was awarded a scholarship from the Egyptian and Danish governments for two years to work on his PhD project. As part of his time as a PhD student, Mohamed worked at University of Copenhagen, Denmark on a project focused on α7 nAChR and NMDA receptors interaction in healthy and Alzheimer's disease brain tissues from both human and mice. He also worked abroad on other related projects, like organotypic brain slice culturing and chronic pain, produced a substantial amount of quality that so far has resulted in publications in international peer-reviewed scientific journals. He was awarded a researcher assistant ‘Part-time’ job for one year at the Department of Drug Design and Pharmacology, University of Copenhagen, Denmark, and actively participated in many international conferences especially on Alzheimer's disease & other brain disorders. He is a member of many scientific societies in Egypt, a member at Federation of European Neuroscience Societies (FENS) [2016], and trainer at Arab Society of Stem Cells and Molecular Biology (ASSCMB). He also supervised and mentored for some Bachelor and Master students during study abroad, this helps greatly for their graduations. Now, Dr. Elnagar is a Lecturer and Researcher at the Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. He is also developing a new research line of Behavioral- and Neuro- Pharmacology at the department in Egypt. He started his small research group, and continue working in a collaboration with other international scientists in different scientific aspects related to his major field with giving special interest to researches focusing on the progression of Alzheimer's disease, rodent models of cerebral ischemia, chronic pain, nicotine addiction and stress-related disorders.

Dr. Mohamed R. Elnagar Research Interests includes Neuronal receptors interactions, Alzheimer's disease, Cerebral ischemia, Chronic pain, Nicotine addiction.